INNOVA CAPTAB
Back to Cashflow Statement
|
INNOVA CAPTAB Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹361 Cr | ₹27 Cr | ₹125 Cr | ₹-19 Cr | ₹-23 Cr |
What is the latest Cash Flow from Financing Activities ratio of INNOVA CAPTAB ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹361 Cr |
Mar2023 | ₹27 Cr |
Mar2022 | ₹125 Cr |
Mar2021 | ₹-19 Cr |
Mar2020 | ₹-23 Cr |
How is Cash Flow from Financing Activities of INNOVA CAPTAB Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹361 Cr | 1,231.88 | |
Mar2023 | ₹27 Cr | -78.25 | |
Mar2022 | ₹125 Cr | Positive | |
Mar2021 | ₹-19 Cr | Negative | |
Mar2020 | ₹-23 Cr | - |
Compare Cash Flow from Financing Activities of peers of INNOVA CAPTAB
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INNOVA CAPTAB | ₹5,405.7 Cr | 6% | 2.3% | 74.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,768.0 Cr | 0.4% | -1.2% | 12.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,468.0 Cr | 2.6% | 8.4% | 48.5% | Stock Analytics | |
CIPLA | ₹121,326.0 Cr | -0.1% | 0.5% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,757.0 Cr | 3.2% | 11.8% | 11.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,345.0 Cr | 3.4% | 0.5% | 12.8% | Stock Analytics |
INNOVA CAPTAB Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INNOVA CAPTAB | 6% |
2.3% |
74.9% |
SENSEX | 0.3% |
0.7% |
8.8% |
You may also like the below Video Courses